These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18655832)

  • 1. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
    Duquesnoy RJ
    Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?
    Duquesnoy RJ
    Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.
    Duquesnoy RJ
    Tissue Antigens; 2011 Jun; 77(6):525-34. PubMed ID: 21410655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA matching at the epitope level: the way to go.
    Duquesnoy RJ
    Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
    Duquesnoy RJ
    Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Marrari M; Mostecki J; Mulder A; Claas F; Balazs I; Duquesnoy RJ
    Transplantation; 2010 Dec; 90(12):1468-72. PubMed ID: 21063243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
    Duquesnoy RJ; Claas FH
    Tissue Antigens; 2007 Apr; 69 Suppl 1():180-4. PubMed ID: 17445196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunogenicity of HLA mismatches in clinical transplantation.
    Claas FH; Dankers MK; Oudshoorn M; van Rood JJ; Mulder A; Roelen DL; Duquesnoy RJ; Doxiadis II
    Transpl Immunol; 2005 Aug; 14(3-4):187-91. PubMed ID: 15982562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.
    Duquesnoy RJ; Marrari M; Mulder A; Sousa LC; da Silva AS; do Monte SJ
    Tissue Antigens; 2014 Jun; 83(6):391-400. PubMed ID: 24828056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.